Your browser doesn't support javascript.
loading
Preoperative Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Test at Between 48 and 72 Hours Preoperatively is Safe for Patients Undergoing Primary and Revision Hip and Knee Arthroplasty: A Multicentre International Study.
Hamilton, Thomas W; Ingelsrud, Lina H; Gutman, Michael; Shearman, Alexander D; Gromov, Kirill; Alvand, Abtin; Troelsen, Anders; Parvizi, Javad; Price, Andrew J.
Afiliação
  • Hamilton TW; Nuffield Orthopaedic Centre, Oxford, UK.
  • Ingelsrud LH; Copenhagen University Hospital Hvidovre, Copenhagen, Denmark.
  • Gutman M; Rothman Orthopaedic Institute, Philadelphia, PA.
  • Shearman AD; Nuffield Orthopaedic Centre, Oxford, UK.
  • Gromov K; Copenhagen University Hospital Hvidovre, Copenhagen, Denmark.
  • Alvand A; Nuffield Orthopaedic Centre, Oxford, UK.
  • Troelsen A; Copenhagen University Hospital Hvidovre, Copenhagen, Denmark.
  • Parvizi J; Rothman Orthopaedic Institute, Philadelphia, PA.
  • Price AJ; Nuffield Orthopaedic Centre, Oxford, UK.
J Arthroplasty ; 37(7): 1253-1259, 2022 07.
Article em En | MEDLINE | ID: mdl-35307532
ABSTRACT

BACKGROUND:

Patients undergoing lower limb arthroplasty who are severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive at the time of surgery have a high risk of mortality. The National Institute for Health and Clinical Care Excellence and the British Orthopaedic Association advise self-isolation for 14 days preoperatively in patients at a high risk of adverse outcomes due to COVID-19. The aim of the study is to assess whether preoperative polymerase chain reaction (PCR) for SARS-CoV-2 could be performed at between 48 and 72 hours preoperatively with specific advice about minimizing the risk of SARS-CoV-2 restricted to between PCR and admission.

METHODS:

A multicentre, international, observational cohort study of 1,000 lower limb arthroplasty cases was performed. The dual primary outcomes were 30-day conversion to SARS-CoV-2 positive and 30-day SARS-CoV-2 mortality. Secondary outcomes included 30-day SARS-CoV-2 morbidity.

RESULTS:

Of the 1,000 cases, 935 (94%) had a PCR between 48 and 72 hours preoperatively. All cases were admitted to and had surgery through a COVID-free pathway. Primary knee arthroplasty was performed in 41% of cases, primary hip arthroplasty in 40%, revision knee arthroplasty in 11%, and revision hip arthroplasty in 9%. Six percent of operations were emergency operations. No cases of SARS-CoV-2 were identified within the first 30 days.

CONCLUSION:

Preoperative SARS-CoV-2 PCR test between 48 and 72 hours preoperatively with advice about minimizing the risk of SARS-CoV-2 restricted to between PCR and admission in conjunction with a COVID-free pathway is safe for patients undergoing primary and revision hip and knee arthroplasty. Preoperative SARS-CoV-2 PCR test alone may be safe but further adequately powered studies are required. This information is important for shared decision making with patients during the current pandemic.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artroplastia do Joelho / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Arthroplasty Assunto da revista: ORTOPEDIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artroplastia do Joelho / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Arthroplasty Assunto da revista: ORTOPEDIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido